Tampa General Hospital CEO: Change Healthcare will have to give an update soon

The latest stories trending on MedCity News.

Editor's Pick

Top Story Tampa General Hospital CEO on Change Healthcare Breach: They Are Going To Have To Give an Update Soon In an interview at the Vive conference in Los Angeles, John Couris said that while he is sympathetic toward Change Healthcare's current woes, he wants definitive answers soon. Calling All Women's Health Startups Need more funding? Looking for new partnerships? This is your chance to get in front of healthcare's best industry experts and VCs. Apply to Pitch at INVEST 2024 May 21-22 in Chicago. Winners will receive a $20K branding advertising package. You don't want to miss this opportunity to share how your company is making a difference in biopharma oncology. Deadline to apply is approaching fast, Feb 29th. Apply Now

Featured News

16 Health Systems Help Launch Health & Wellness Marketplace Vale Health announced its launch on Monday at ViVE. The startup's platform helps health systems connect their patients to health and wellness products, which are becoming increasingly interesting to consumers. Vale has 16 founding health systems partners that will go live with the platform, with the Froedtert & the Medical College of Wisconsin health network being the first. Highmark Health Collaborates with Epic, Google Cloud To Improve Payer/Provider Coordination Epic's Payer Platform is being integrated with Highmark's claims data on Google Cloud, the companies announced Monday at ViVE. This will give providers better insight into patients' health. Boehringer Ingelheim's Liver Drug Data Position It for MASH Clash With Eli Lilly Preliminary Phase 2 results show 83% of those treated with Boehringer Ingelheim and Zealand Pharma drug survodutide met the main goal of improvement in the fatty liver disease MASH. Boehringer contends this drug has best-in-class potential in a competitive field that includes an Eli Lilly drug that recently posted positive Phase 2 results. Breaking Silos: The Power of Collaboration in Minimizing Denials for Better Revenue Cycle Performance The combination of technology and cross-functional collaboration allows providers to address denials and achieve optimal revenue performance. What to Expect from Your Language Services Provider during CMS Test Call Season Performance on these test calls impacts the organization's Star Rating, which is a marker of plan quality published on the Medicare Pathfinder. A lower rating can mean the loss of millions of dollars in reimbursements.

Resources

MedCity FemFwd: What Male Birth Control Means for Women's Health In this episode of MedCity FemFwd, we were joined by Régine Sitruk-Ware, a distinguished scientist at the Population Council's Center for Biomedical Research (CBR), and Chelsea Polis, senior scientist of epidemiology at CBR. Sitruk-Ware and Polis discuss what the development of a male birth control product could mean for women's health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe